SEC 13F Intelligence

Yong Rong (Hk) Asset Management Ltd / RXRX

Yong Rong (Hk) Asset Management Ltd’s Recursion Pharmaceuticals In Position

Does Yong Rong (Hk) Asset Management Ltd own Recursion Pharmaceuticals In (RXRX)? Not currently — the last reported position was 1.17M shares worth $9M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$9M
Q2 2023
Shares
1.17M
% of Portfolio
+3.85%
Quarters Held
2
position exited

Position History RXRX

Reported value by quarter
Q3 ’21: $9MQ3 ’21Q2 ’23: $9MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20231.17M$9M+3.85%
Q3 2021377.0K$9M+5.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Yong Rong (Hk) Asset Management Ltd’s full portfolio or all institutional holders of RXRX.